Page values for "Insulin Lispro"

Nav

"Medicines" values

1 row is stored for this page

Field	Field type	Value
generic	`String`	Insulin lispro
brand	`String`	Humalog, Admelog, Lyumjev
structure	`File`
classes	List of `String`, delimiter: `,`	[[:Category:Insulins\|Insulin]] • [[:Category:Rapid-acting_insulins\|Rapid-acting insulin analog]] • [[:Category:Mealtime_insulins\|Mealtime (bolus) insulin]]
mechanism	`String`	'"`UNIQ--vote-00000584-QINU`"' Binds the same insulin receptor as endogenous insulin with comparable mitogenic-to-metabolic ratio. Ultra-rapid formulations (Lyumjev) add treprostinil and citrate to accelerate absorption further'"`UNIQ--ref-00000585-QINU`"'.
uses	`String`	'"`UNIQ--vote-00000586-QINU`"', '"`UNIQ--vote-00000587-QINU`"', '"`UNIQ--vote-00000588-QINU`"'
starting_dose	`String`	SC 4-6 units (or 1 unit per 10-15 g carbs) at meals; titrate to postprandial glucose. Typical total daily dose 0.5-1 U/kg/d split between basal and prandial coverage in T1DM
preparations	`String`	100 U/mL (Humalog, Admelog, Lyumjev) vials, pens, cartridges; 200 U/mL Humalog KwikPen
fda_max	`String`	Titrated to glucose; no fixed maximum
pill_id	`Text`
routes	List of `String`, delimiter: `,`	Subcutaneous • IV (continuous infusion for DKA) • insulin pumps
onset	`String`	SC: 5-15 minutes; ultra-rapid Lyumjev faster
duration	`String`	3-5 hours
halflife	`String`	~1 hour SC'"`UNIQ--ref-00000589-QINU`"'
bioavailability	`String`	~100% from subcutaneous depot
pregnancy	`String`	Insulin is the preferred glucose-lowering therapy in pregnancy; lispro is widely used.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed\|citation needed]]]</sup>
legal	`String`	[[USLegal:Prescription only\|Rx-only]] in US (some OTC formulations exist)